Week's Most Significant Insider Trades: May 7 - 11, 2018

Disposals:

Apple (NASDAQ:AAPL) insider Angela J. Ahrendts sold 38,228 shares of the stock in a transaction dated Friday, May 4th. The stock was sold at an average price of $176.54, for a total transaction of $6,748,771.12. Following the transaction, the insider now owns 90,967 shares in the company, valued at $16,059,314.18. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Read more …

Apple (NASDAQ:AAPL) COO Jeffrey E. Williams sold 15,653 shares of the business’s stock in a transaction on Tuesday, May 8th. The stock was sold at an average price of $185.18, for a total transaction of $2,898,622.54. Following the transaction, the chief operating officer now owns 168,181 shares of the company’s stock, valued at approximately $31,143,757.58. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Read more …

Apple (NASDAQ:AAPL) Director Arthur D. Levinson sold 35,000 shares of the business’s stock in a transaction that occurred on Wednesday, May 9th. The shares were sold at an average price of $185.99, for a total transaction of $6,509,650.00. Following the completion of the sale, the director now owns 1,168,283 shares of the company’s stock, valued at $217,288,955.17. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Shares of NASDAQ:AAPL traded down $1.45 on Friday, reaching $188.59. 26,184,751 shares of the company’s stock were exchanged, compared to its average volume of 36,315,044. The stock has a market capitalization of $950.67 billion, a price-to-earnings ratio of 20.48, a price-to-earnings-growth ratio of 1.39 and a beta of 1.26. Apple has a fifty-two week low of $187.45 and a fifty-two week high of $190.06. The company has a debt-to-equity ratio of 0.80, a quick ratio of 1.37 and a current ratio of 1.46. Read more …

Parker Hannifin (NYSE:PH) VP Andrew M. Weeks sold 2,600 shares of the stock in a transaction that occurred on Monday, May 7th. The shares were sold at an average price of $169.36, for a total transaction of $440,336.00. Following the transaction, the vice president now owns 6,160 shares in the company, valued at $1,043,257.60. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Shares of Parker Hannifin stock traded up $0.52 on Tuesday, hitting $171.03. The stock had a trading volume of 576,022 shares, compared to its average volume of 1,226,307. The company has a debt-to-equity ratio of 0.82, a quick ratio of 1.09 and a current ratio of 1.59. Parker Hannifin has a one year low of $151.17 and a one year high of $212.80. The stock has a market capitalization of $22.73 billion, a price-to-earnings ratio of 21.08, a P/E/G ratio of 1.46 and a beta of 1.44. Read more …

Waste Management (NYSE:WM) SVP Barry H. Caldwell sold 10,844 shares of Waste Management stock in a transaction on Friday, May 4th. The stock was sold at an average price of $84.00, for a total transaction of $910,896.00. Following the completion of the transaction, the senior vice president now owns 31,447 shares in the company, valued at approximately $2,641,548. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Shares of NYSE:WM traded down $0.17 on Tuesday, hitting $83.05. 1,129,613 shares of the company were exchanged, compared to its average volume of 2,374,341. Waste Management has a one year low of $70.08 and a one year high of $89.73. The company has a debt-to-equity ratio of 1.47, a quick ratio of 0.71 and a current ratio of 0.74. The company has a market cap of $36.25 billion, a price-to-earnings ratio of 25.71, a PEG ratio of 1.72 and a beta of 0.70. Read more …

Boeing (NYSE:BA) EVP J Michael Luttig sold 9,000 shares of the business’s stock in a transaction dated Wednesday, May 9th. The shares were sold at an average price of $344.13, for a total value of $3,097,170.00. Following the sale, the executive vice president now directly owns 27,878 shares of the company’s stock, valued at approximately $9,593,656.14. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. BA stock traded down $0.43 during midday trading on Thursday, reaching $344.07. 3,919,172 shares of the company traded hands, compared to its average volume of 4,464,841. Boeing has a 52-week low of $342.41 and a 52-week high of $348.57. The company has a debt-to-equity ratio of 8.07, a current ratio of 1.15 and a quick ratio of 0.33. The company has a market cap of $197.13 billion, a PE ratio of 28.58, a price-to-earnings-growth ratio of 1.68 and a beta of 1.39. Read more …

Notable Analyst Upgrades and Downgrades for Week of November 13, 2017

Upgrades:

Automatic Data Processing (NYSE:ADP) was upgraded by investment analysts at Morgan Stanley from an “underweight” rating to an “equal” rating in a research report issued to clients and investors on Tuesday. A number of other brokerages have also issued reports on ADP. BidaskClub raised shares of Automatic Data Processing from a “hold” rating to a “buy” rating in a report on Thursday, September 28th. BMO Capital Markets cut their price objective on shares of Automatic Data Processing from $122.00 to $114.00 and set an “outperform” rating for the company in a report on Friday, November 3rd. Bank of America Corporation increased their price objective on shares of Automatic Data Processing from $111.00 to $114.00 and gave the company a “neutral” rating in a report on Friday, October 13th. Barclays PLC reaffirmed an “equal weight” rating and set a $105.00 price objective on shares of Automatic Data Processing in a report on Tuesday, August 15th. Read more …

Air Products and Chemicals, Inc. (NYSE:APD) was upgraded by investment analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating in a research note issued on Monday, The Fly reports. A number of other brokerages also recently commented on APD. Deutsche Bank AG boosted their target price on shares of Air Products and Chemicals from $160.00 to $168.00 and gave the stock a “hold” rating in a report on Wednesday, August 2nd. Susquehanna Bancshares Inc boosted their target price on shares of Air Products and Chemicals and gave the stock a “positive” rating in a report on Tuesday, November 7th. Jefferies Group LLC reiterated a “hold” rating and issued a $155.00 target price on shares of Air Products and Chemicals in a report on Thursday, September 28th. SunTrust Banks, Inc. reiterated a “buy” rating and issued a $175.00 target price on shares of Air Products and Chemicals in a report on Friday, October 27th. Read more …

Coca-Cola Company (The) (NYSE:KO) was upgraded by investment analysts at Wells Fargo & Company from a “market perform” rating to an “outperform” rating in a note issued to investors on Tuesday, The Fly reports. Several other equities research analysts have also recently weighed in on the company. Vetr upgraded Coca-Cola Company (The) from a “sell” rating to a “strong-buy” rating in a research note on Tuesday, September 12th. Royal Bank Of Canada set a $49.00 target price on Coca-Cola Company (The) and gave the company a “buy” rating in a report on Sunday. UBS AG boosted their target price on Coca-Cola Company (The) from $49.00 to $51.00 and gave the company a “buy” rating in a report on Thursday, July 27th. Read more …

Sanofi (NYSE:SNY) was upgraded by equities research analysts at Barclays PLC from an “underweight” rating to an “equal weight” rating in a research report issued on Wednesday. A number of other research firms also recently weighed in on SNY. Zacks Investment Research downgraded Sanofi from a “hold” rating to a “strong sell” rating in a research report on Friday, October 6th. raised Sanofi from a “reduce” rating to a “hold” rating in a research report on Wednesday, August 30th. Argus reissued a “buy” rating and set a $55.00 target price on shares of Sanofi in a research report on Friday, September 1st. J P Morgan Chase & Co reissued a “neutral” rating on shares of Sanofi in a research report on Friday, September 15th. Finally, BidaskClub raised Sanofi from a “sell” rating to a “hold” rating in a research report on Saturday, August 5th. Read more ...

Occidental Petroleum Corporation (NYSE:OXY) was upgraded by stock analysts at The Goldman Sachs Group, Inc. from a “neutral” rating to a “buy” rating in a report released on Friday. A number of other research analysts have also weighed in on OXY. Morgan Stanley raised their price target on shares of Occidental Petroleum Corporation from $62.00 to $66.00 and gave the company an “equal weight” rating in a research note on Wednesday, October 18th. Jefferies Group LLC set a $58.00 price target on shares of Occidental Petroleum Corporation and gave the company a “hold” rating in a research report on Tuesday, August 29th. Read more …

Downgrades:

Argus lowered shares of Gilead Sciences, Inc. (NASDAQ:GILD) from a buy rating to a hold rating in a research report released on Monday morning. Argus currently has $73.77 target price on the biopharmaceutical company’s stock, up from their previous target price of $73.25. Several other equities research analysts have also recently issued reports on the stock. Mizuho lifted their price objective on shares of Gilead Sciences from $77.00 to $83.00 and gave the company a buy rating in a research report on Wednesday, November 8th. Maxim Group reiterated a hold rating on shares of Gilead Sciences in a research report on Friday, October 27th. BMO Capital Markets reduced their price objective on shares of Gilead Sciences from $89.00 to $83.00 and set an outperform rating on the stock in a research report on Friday, October 27th. J P Morgan Chase & Co set a $85.00 price objective on shares of Gilead Sciences and gave the company a buy rating in a research report on Wednesday, October 25th. Read more …

J P Morgan Chase & Co downgraded shares of Rio Tinto PLC (NYSE:RIO) from an overweight rating to a neutral rating in a research report report published on Monday morning, MarketBeat Ratings reports. Other equities research analysts have also issued research reports about the stock. Societe Generale upgraded shares of Rio Tinto PLC from a hold rating to a buy rating in a research note on Wednesday, November 8th. Citigroup Inc. downgraded shares of Rio Tinto PLC from a buy rating to a neutral rating in a research note on Tuesday, October 17th. Cowen and Company set a $47.00 price target on shares of Rio Tinto PLC and gave the company a hold rating in a report on Monday, October 16th. Clarkson Capital lowered shares of Rio Tinto PLC from a buy rating to a neutral rating in a research report on Monday, October 16th. Read more …

Schlumberger N.V. (NYSE:SLB) was downgraded by investment analysts at Goldman Sachs Group, Inc. (The) from a “conviction-buy” rating to a “buy” rating in a report released on Monday. They currently have a $75.00 price target on the oil and gas company’s stock. Goldman Sachs Group, Inc. (The)’s price target indicates a potential upside of 19.46% from the stock’s current price. SLB has been the topic of several other reports. Zacks Investment Research lowered Schlumberger N.V. from a “hold” rating to a “sell” rating in a report on Wednesday, November 1st. FBR & Co reissued a “buy” rating on shares of Schlumberger N.V. in a report on Friday, October 20th. Piper Jaffray Companies set a $74.00 target price on Schlumberger N.V. and gave the stock a “buy” rating in a report on Saturday, October 21st. Sanford C. Bernstein reissued an “outperform” rating and set a $80.00 target price on shares of Schlumberger N.V. in a report on Wednesday, September 6th. Read more …

J P Morgan Chase & Co downgraded shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) from a neutral rating to an underweight rating in a report published on Monday morning. The firm currently has $11.00 price objective on the stock, down from their previous price objective of $11.48. A number of other research firms have also recently weighed in on TEVA. Jefferies Group LLC restated a hold rating on shares of Teva Pharmaceutical Industries Limited in a report on Tuesday, July 25th. Vetr upgraded Teva Pharmaceutical Industries Limited from a hold rating to a buy rating and set a $34.17 price target on the stock in a report on Monday, July 24th. Zacks Investment Research upgraded Teva Pharmaceutical Industries Limited from a sell rating to a hold rating in a report on Monday, July 17th. Royal Bank Of Canada restated an outperform rating and issued a $37.00 price target (down previously from $38.00) on shares of Teva Pharmaceutical Industries Limited in a report on Monday, July 17th. Read more …

Phillips 66 (NYSE:PSX) was downgraded by stock analysts at Barclays PLC from an “equal weight” rating to an “underweight” rating in a note issued to investors on Tuesday. They presently have a $100.00 price target on the oil and gas company’s stock, up from their prior price target of $95.00. Barclays PLC’s price target indicates a potential upside of 7.49% from the company’s previous close. A number of other analysts have also recently weighed in on PSX. Scotiabank set a $86.00 price target on Phillips 66 and gave the company a “hold” rating in a research report on Tuesday, August 1st. BidaskClub cut Phillips 66 from a “hold” rating to a “sell” rating in a research report on Friday, August 18th. Jefferies Group LLC reiterated a “hold” rating and issued a $78.00 price target on shares of Phillips 66 in a research report on Tuesday, September 5th. Piper Jaffray Companies reiterated a “buy” rating and issued a $98.00 price target on shares of Phillips 66 in a research report on Tuesday, September 26th. Read more ...

Cardinal Health, Inc. (NYSE:CAH) was downgraded by stock analysts at Argus from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday. Several other equities analysts have also recently commented on CAH. Jefferies Group LLC lowered their price target on shares of Cardinal Health from $77.00 to $67.00 and set a “hold” rating on the stock in a report on Tuesday, November 7th. Zacks Investment Research upgraded shares of Cardinal Health from a “sell” rating to a “hold” rating in a report on Wednesday, November 8th. BidaskClub cut shares of Cardinal Health from a “hold” rating to a “sell” rating in a report on Friday, August 4th. Credit Suisse Group decreased their price objective on shares of Cardinal Health from $87.00 to $81.00 and set an “outperform” rating for the company in a report on Thursday, August 3rd. Read more ...

Williams-Sonoma, Inc. (NYSE:WSM) was downgraded by research analysts at J P Morgan Chase & Co from an “overweight” rating to an “underweight” rating in a research note issued to investors on Friday. A number of other research firms have also issued reports on WSM. Robert W. Baird set a $48.00 price target on Williams-Sonoma and gave the company a “hold” rating in a research report on Tuesday, October 31st. Zacks Investment Research lowered Williams-Sonoma from a “buy” rating to a “sell” rating in a research report on Wednesday. TheStreet raised Williams-Sonoma from a “c+” rating to a “b-” rating in a research report on Monday, October 9th. Credit Suisse Group lowered Williams-Sonoma from a “neutral” rating to an “underperform” rating and set a $44.00 target price on the stock. in a research report on Thursday, October 12th. Read more …

In case you interested of stock analysis of other bloggers, click on link below:

Analysis Collection

Notable Analyst Upgrades and Downgrades for Week of October 30, 2017

Upgrades:

Intel Corporation (NASDAQ:INTC) was upgraded by stock analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating in a research report issued to clients and investors on Monday. Other equities analysts have also recently issued reports about the company. Canaccord Genuity restated a “buy” rating and set a $38.00 price objective on shares of Intel Corporation in a research note on Wednesday, July 12th. Hilliard Lyons initiated coverage on Intel Corporation in a research note on Wednesday, July 12th. They set a “buy” rating and a $41.00 price objective on the stock. Needham & Company LLC restated a “buy” rating and set a $43.00 price objective on shares of Intel Corporation in a research note on Wednesday, July 12th. Read more …

Merck & Company, Inc. (NYSE:MRK) was upgraded by equities researchers at Citigroup Inc. to a “buy” rating in a report released on Monday. A number of other research firms have also recently weighed in on MRK. Zacks Investment Research cut Merck & from a “hold” rating to a “sell” rating in a report on Wednesday, October 11th. BMO Capital Markets reaffirmed a “buy” rating and set a $72.00 price target on shares of Merck & in a report on Friday, September 8th. UBS AG raised their price target on Merck & from $70.00 to $72.00 and gave the company a “buy” rating in a report on Monday, July 31st. Piper Jaffray Companies set a $70.00 price target on Merck & and gave the company a “buy” rating in a report on Saturday, July 29th. Finally, BidaskClub raised Merck & from a “sell” rating to a “hold” rating in a research note on Tuesday, August 1st. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and nine have assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and a consensus target price of $69.21. Read more …

Goldman Sachs Group, Inc. (The) upgraded shares of ABB Ltd (NYSE:ABB) from a neutral rating to a conviction-buy rating in a research note issued to investors on Tuesday morning. A number of other research analysts have also recently commented on ABB. BidaskClub cut shares of ABB from a buy rating to a hold rating in a research report on Tuesday, August 1st. Robert W. Baird reaffirmed a buy rating and issued a $29.00 target price on shares of ABB in a research report on Wednesday, October 4th. Zacks Investment Research cut shares of ABB from a hold rating to a sell rating in a research report on Tuesday, September 19th. UBS AG reaffirmed a sell rating on shares of ABB in a research report on Monday, July 24th. Read more …

Kimberly-Clark Corporation (NYSE:KMB) was upgraded by research analysts at Societe Generale from a “hold” rating to a “buy” rating in a report released on Thursday, Marketbeat Ratings reports. The brokerage currently has a $144.00 price objective on the stock, up from their prior price objective of $112.05. Societe Generale’s price objective suggests a potential upside of 27.99% from the stock’s previous close. A number of other analysts have also weighed in on the company. J P Morgan Chase & Co lowered Kimberly-Clark Corporation from a “neutral” rating to an “underweight” rating and lowered their target price for the stock from $115.55 to $100.00 in a report on Friday, October 20th. Macquarie initiated coverage on Kimberly-Clark Corporation in a report on Friday, September 15th. Read more …

Downgrades:

General Motors Company (NYSE:GM) (TSE:GMM.U) was downgraded by analysts at Goldman Sachs Group, Inc. (The) from a “neutral” rating to a “sell” rating in a research report issued on Monday. They presently have a $32.00 price target on the auto manufacturer’s stock, down from their previous price target of $43.16. Goldman Sachs Group, Inc. (The)’s target price would indicate a potential downside of 25.55% from the stock’s current price. A number of other equities analysts have also issued reports on the stock. Deutsche Bank AG boosted their target price on shares of General Motors from $51.00 to $52.00 and gave the stock a “buy” rating in a research report on Wednesday, October 25th. BMO Capital Markets raised shares of General Motors to a “market perform” rating and boosted their target price for the stock from $41.00 to $48.00 in a research report on Wednesday, October 25th. Read more …

Merck & Company, Inc. (NYSE:MRK) was downgraded by Morgan Stanley from an “overweight” rating to an “equal weight” rating in a note issued to investors on Monday, Marketbeat reports. They currently have a $56.00 target price on the stock. Morgan Stanley’s target price points to a potential downside of 3.85% from the company’s current price. Other equities research analysts also recently issued reports about the company. BMO Capital Markets restated an “outperform” rating and issued a $73.00 price target (down from $74.00) on shares of Merck & in a report on Monday, July 24th. Read more …

Statoil ASA (NYSE:STO) was downgraded by analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating in a report issued on Monday. Several other brokerages have also recently commented on STO. BNP Paribas upgraded shares of Statoil ASA from an “underperform” rating to a “neutral” rating in a research report on Tuesday, September 26th. Tudor Pickering cut shares of Statoil ASA from a “buy” rating to a “hold” rating in a research report on Tuesday, September 5th. Deutsche Bank AG upgraded shares of Statoil ASA from a “sell” rating to a “hold” rating in a research report on Monday, September 4th. Scotiabank set a $17.00 target price on shares of Statoil ASA and gave the company a “hold” rating in a research report on Friday, August 25th. Read more …

Nokia Corporation (NYSE:NOK) was downgraded by equities research analysts at Argus from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Monday. NOK has been the subject of several other reports. Zacks Investment Research lowered Nokia Corporation from a “buy” rating to a “hold” rating in a research report on Monday, July 17th. Vetr raised Nokia Corporation from a “buy” rating to a “strong-buy” rating and set a $7.28 target price for the company in a research report on Friday, July 14th. Read more …

Bank of America Corporation downgraded shares of Under Armour Inc (NYSE:UAA) from a neutral rating to an underperform rating in a report issued on Monday. They currently have $12.00 price target on the stock, down from their prior price target of $21.00. Several other research firms also recently weighed in on UAA. Zacks Investment Research upgraded Under Armour from a hold rating to a buy rating and set a $24.00 target price on the stock in a research report on Tuesday, July 4th. Vetr upgraded Under Armour from a hold rating to a buy rating and set a $22.36 price objective on the stock in a research report on Monday, July 3rd. Susquehanna Bancshares Inc lifted their price objective on Under Armour from $14.00 to $17.00 in a research report on Friday, July 7th. Read more …

Under Armour Inc (NYSE:UAA) was downgraded by equities researchers at J P Morgan Chase & Co from a “neutral” rating to an “underweight” rating in a report released on Tuesday. Read more …

Argus downgraded shares of Amgen Inc. (NASDAQ:AMGN) from a buy rating to a hold rating in a research report report published on Wednesday. The brokerage currently has $195.00 price objective on the medical research company’s stock, up from their prior price objective of $175.22. “We would consider a more constructive stance on AMGN on signs of stronger contributions from the company’s new drug pipeline or from its biosimilars portfolio,” the firm said.”We note, however, that Amgen may not generate commercial revenue from biosimilars until 2019 due to regulatory and legal hurdles.,” Argus’ analyst wrote. Read more …

Teva Pharmaceutical Industries Limited (NYSE:TEVA) was downgraded by research analysts at Wells Fargo & Company to a “market perform” rating in a research note issued to investors on Thursday, The Fly reports. They presently have a $11.36 target price on the stock, down from their previous target price of $17.00. Wells Fargo & Company’s price objective suggests a potential downside of 17.68% from the stock’s current price. A number of other research firms have also issued reports on TEVA. TheStreet lowered shares of Teva Pharmaceutical Industries Limited from a “c-” rating to a “d+” rating in a research note on Friday, August 25th. Read more …

Teva Pharmaceutical Industries Limited (NYSE:TEVA) was downgraded by equities researchers at Deutsche Bank AG from a “buy” rating to a “hold” rating in a research note issued to investors on Friday. Read more …

Royal Dutch Shell PLC (NYSE:RDS.B) was downgraded by analysts at Societe Generale from a “buy” rating to a “hold” rating in a research note issued on Friday, The Fly reports. Read more …

In case you interested of stock analysis of other bloggers, click on link below:

Analysis Collection

Notable Analyst Upgrades and Downgrades for Week of August 21, 2017

Upgrades:

Toronto-Dominion Bank (TSE:TD) (NYSE:TD) was upgraded by analysts at Scotiabank from a “sector perform” rating to an “outperform” rating in a report released on Monday. The brokerage currently has a C$73.00 target price on the stock, up from their previous target price of C$71.00. Scotiabank’s target price suggests a potential upside of 14.55% from the stock’s previous close. Other analysts have also issued research reports about the company. Barclays PLC increased their price objective on Toronto-Dominion Bank from C$69.00 to C$70.00 in a report on Friday, August 11th. Read more …

Eaton Vance Corporation (NYSE:EV) was upgraded by equities research analysts at J P Morgan Chase & Co from an “underweight” rating to a “neutral” rating in a report issued on Thursday, The Fly reports. A number of other equities analysts have also recently issued reports on the company. Bank of America Corporation increased their target price on Eaton Vance Corporation from $47.00 to $49.00 and gave the stock a “neutral” rating in a report on Thursday, May 25th. Read more …

Downgrades:

Royal Bank Of Canada (NYSE:RY) (TSE:RY) was downgraded by stock analysts at Scotiabank from an “outperform” rating to a “sector perform” rating in a research report issued on Monday. Other analysts also recently issued reports about the stock. Zacks Investment Research upgraded shares of Royal Bank Of Canada from a “sell” rating to a “buy” rating and set a $83.00 target price on the stock in a report on Wednesday, August 9th. Canaccord Genuity started coverage on shares of Royal Bank Of Canada in a report on Tuesday, July 18th. They issued a “hold” rating on the stock. Read more …

Brookfield Infrastructure Partners LP (NYSE:BIP) (TSE:BIP.UN) was downgraded by investment analysts at Credit Suisse Group from an “outperform” rating to a “neutral” rating in a report issued on Tuesday. BIP has been the topic of several other research reports. Zacks Investment Research raised shares of Brookfield Infrastructure Partners from a “hold” rating to a “buy” rating and set a $46.00 price target on the stock in a report on Friday, June 2nd. Royal Bank Of Canada lifted their price target on shares of Brookfield Infrastructure Partners from $40.00 to $44.00 and gave the company an “outperform” rating in a report on Friday, May 5th. Read more …

Credit Suisse Group lowered shares of Deere & Company (NYSE:DE) from a neutral rating to an outperform rating in a research note released on Tuesday. A number of other research firms have also weighed in on DE. BidaskClub lowered shares of Deere & from a buy rating to a hold rating in a report on Wednesday, June 28th. Barclays PLC upped their target price on shares of Deere & from $82.00 to $90.00 and gave the stock a sell rating in a report on Monday, May 22nd. Read more …

Citigroup Inc. lowered shares of BHP Billiton plc (LON:BLT) to a neutral rating in a research report sent to investors on Wednesday morning. Citigroup Inc. currently has GBX 1,400 ($18.17) price objective on the mining company’s stock, up from their prior price objective of GBX 1,350 ($17.53). Several other brokerages have also recently issued reports on BLT. UBS AG set a GBX 1,375 ($17.85) price target on BHP Billiton plc and gave the company a buy rating in a research report on Tuesday. Goldman Sachs Group, Inc. (The) restated a sell rating and issued a GBX 1,075 ($13.96) price target on shares of BHP Billiton plc in a research report on Tuesday. Read more …

Lowe’s Companies, Inc. (NYSE:LOW) was downgraded by BMO Capital Markets from an “outperform” rating to a “market perform” rating in a research note issued to investors on Wednesday, The Fly reports. Other analysts also recently issued research reports about the stock. Credit Suisse Group set a $94.00 price target on shares of Lowe’s Companies and gave the company a “buy” rating in a report on Tuesday, May 2nd. Read more …

Teva Pharmaceutical Industries Limited (NYSE:TEVA) was downgraded by stock analysts at Credit Suisse Group from a “neutral” rating to an “underperform” rating in a note issued to investors on Wednesday, The Fly reports. Several other equities research analysts also recently weighed in on TEVA. Citigroup Inc. decreased their price target on shares of Teva Pharmaceutical Industries Limited from $47.00 to $42.00 and set a “buy” rating for the company in a research note on Tuesday, April 25th. Read more …

Whole Foods Market, Inc. (NASDAQ:WFM) was downgraded by equities research analysts at Barclays PLC from an “overweight” rating to an “equal weight” rating in a research report issued on Wednesday, The Fly reports. Several other analysts have also weighed in on WFM. Royal Bank Of Canada upped their target price on Whole Foods Market from $35.00 to $42.00 and gave the company an “outperform” rating in a report on Thursday, April 27th. Read more …

J.M. Smucker Company (The) (NYSE:SJM) was downgraded by equities researchers at J P Morgan Chase & Co from an “overweight” rating to a “neutral” rating in a research note issued to investors on Thursday. Other research analysts have also issued research reports about the company. Citigroup Inc. cut their price objective on J.M. Smucker Company (The) from $161.00 to $155.00 and set a “buy” rating for the company in a report on Tuesday, May 9th. Read more …

Hormel Foods Corp (HRL) was Downgraded by Credit Suisse to ” Neutral”. Earlier the firm had a rating of “Outperform ” on the company shares. Credit Suisse advised their Clients and Investors in a research report released on Aug 25, 2017. On the company’s financial health, Hormel Foods Corp reported $0.34 EPS for the quarter, missing the analyst consensus estimate by $ -0.03 based on the information available during the earnings call on Aug 24, 2017. Analyst had a consensus of $0.37. The company had revenue of $2207.40 million for the quarter, compared to analysts expectations of $2241.84 million. The company’s revenue was down -4.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $0.36 EPS. Read more …

Teva Stock Is Getting Destroyed. Is Now The Time To Buy?

Teva (ADR: TEVA) has been a darling for investors in the generic drug sector. Even as recently as last year, investors were eager to see the growth of the company and along with it, the stock price. But then second quarter earnings were reported and Teva stock price hit the fan as they say.

Teva stock price has since cratered 45% since earnings were released and there is no sign of the price coming back. So should investors, particularly value investors take a look at Teva?

In this post, we will look at Teva stock and see whether or not there is a value play here or if you are better served putting your investing dollars elsewhere.

Continue reading …

Notable Analyst Upgrades and Downgrades for Week of August 14, 2017

Upgrades:

Paychex, Inc. (NASDAQ:PAYX) was upgraded by investment analysts at Morgan Stanley from an “underweight” rating to an “equal weight” rating in a research note issued to investors on Wednesday. The brokerage currently has a $55.00 price objective on the business services provider’s stock. Morgan Stanley’s price objective suggests a potential upside of 0.04% from the stock’s previous close. The analysts noted that the move was a valuation call. Continue reading …

Downgrades:

Deere & Company (NYSE:DE) was downgraded by Bank of America Corporation from a “buy” rating to a “neutral” rating in a research note issued on Tuesday, The Fly reports. Continue reading …

Rio Tinto PLC (NYSE:RIO) was downgraded by Royal Bank Of Canada from a “top pick” rating to an “outperform” rating in a research report issued on Tuesday, Marketbeat reports. Continue reading …

Teva Pharmaceutical Industries Limited (NYSE:TEVA) was downgraded by equities research analysts at Citigroup Inc. from a “buy” rating to a “neutral” rating in a research note issued to investors on Wednesday, The Fly reports. Continue reading …

Eaton Corporation, PLC (NYSE:ETN) was downgraded by analysts at J P Morgan Chase & Co from a “neutral” rating to an “underweight” rating in a research note issued to investors on Thursday, The Fly reports. Continue reading …

Illinois Tool Works Inc. (NYSE:ITW) was downgraded by J P Morgan Chase & Co from a “neutral” rating to an “underweight” rating in a note issued to investors on Thursday, Marketbeat Ratings reports. They presently have a $132.00 target price on the industrial products company’s stock. J P Morgan Chase & Co’s price objective would suggest a potential downside of 3.08% from the stock’s current price. Continue reading …

Foot Locker, Inc. (NYSE:FL) was downgraded by stock analysts at Bank of America Corporation from a “neutral” rating to an “underperform” rating in a report released on Friday, The Fly reports. Continue reading …

Why This Billionaire Just Shelled Out $1.1 Billion on 4 Drug Stocks

Allergan, Mylan, Pfizer, and Teva attract a lot of attention and cash from David Tepper's hedge fund, Appaloosa Management.

"A billion here, a billion there, and pretty soon you're talking about real money."

It's debatable who first uttered that phrase. What isn't debatable, though, is that David Tepper and Appaloosa Management are accustomed to throwing around plenty of real money. The multibillion-dollar hedge fund run by Tepper spent over $1.1 billion in the fourth quarter of 2016 on just four drug stocks: Allergan (NYSE:AGN), Mylan (NASDAQ:MYL), Pfizer (NYSE:PFE), and Teva (NYSE:TEVA).

Why so much money on these stocks? And should ordinary investors follow the billionaire's lead? Let's look at what makes these particular pharmaceutical stocks so attractive.

Continue reading here.

Teva Pharmaceutical Industries Limited (TEVA) Upgraded by Bank of America Corporation

Bank of America Corporation upgraded shares of Teva Pharmaceutical Industries Limited (NYSE:TEVA) from a neutral rating to a buy rating in a report released on Tuesday morning.

TEVA has been the topic of a number of other research reports. Deutsche Bank AG cut their price objective on shares of Teva Pharmaceutical Industries Limited from $68.00 to $54.00 and set a buy rating on the stock in a report on Wednesday, November 16th. Morgan Stanley cut shares of Teva Pharmaceutical Industries Limited from an overweight rating to an equal weight rating and cut their price objective for the stock from $63.00 to $42.00 in a report on Sunday, December 4th. Jefferies Group LLC reissued a hold rating and set a $36.00 price objective on shares of Teva Pharmaceutical Industries Limited in a report on Monday, January 9th. Royal Bank Of Canada cut their target price on shares of Teva Pharmaceutical Industries Limited from $71.00 to $58.00 and set an outperform rating on the stock in a report on Monday, November 14th. Finally, BTIG Research cut shares of Teva Pharmaceutical Industries Limited from a buy rating to a neutral rating in a report on Sunday, December 4th. One analyst has rated the stock with a sell rating, thirteen have issued a hold rating, fifteen have assigned a buy rating and one has assigned a strong buy rating to the company. The stock presently has an average rating of Buy and a consensus price target of $55.85.

Source: The Cerbat Gem Investing News and Analysis